| Dr Brett Houghton Woodard, MD | |
|
404 E Calhoun St, Anderson, SC 29621-5803 | |
| (864) 226-1558 | |
| (864) 231-6448 |
| Full Name | Dr Brett Houghton Woodard |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 404 E Calhoun St, Anderson, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699747576 | NPI | - | NPPES |
| 000355693A | Medicaid | GA | |
| 106673 | Medicaid | SC |
| Entity Name | Piedmont Pathology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235101965 PECOS PAC ID: 8729098959 Enrollment ID: O20060502000456 |
News Archive
The Obama administration is launching a national video contest designed to convince young people to sign up for coverage, spending $30,000 on prizes to draw the YouTube generation.
Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially emphysema, which typically emerges in the fourth decade of life. Currently, there are no approved, inhaled treatments available for the treatment of AAT deficiency.
The study is the first on epidemiology and causes of traumatic brain injury in over 20 years. The research team reports in the journal BMJ Open of 4 June 2021.
Choosing among cancer treatments increasingly involves determining whether tumor cells harbor specific, mutated "oncogenes" that drive abnormal growth and that may also be especially vulnerable or resistant to particular drugs.
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brett Houghton Woodard, MD 404 E Calhoun St, Anderson, SC 29621-5803 Ph: (800) 779-4858 | Dr Brett Houghton Woodard, MD 404 E Calhoun St, Anderson, SC 29621-5803 Ph: (864) 226-1558 |
News Archive
The Obama administration is launching a national video contest designed to convince young people to sign up for coverage, spending $30,000 on prizes to draw the YouTube generation.
Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially emphysema, which typically emerges in the fourth decade of life. Currently, there are no approved, inhaled treatments available for the treatment of AAT deficiency.
The study is the first on epidemiology and causes of traumatic brain injury in over 20 years. The research team reports in the journal BMJ Open of 4 June 2021.
Choosing among cancer treatments increasingly involves determining whether tumor cells harbor specific, mutated "oncogenes" that drive abnormal growth and that may also be especially vulnerable or resistant to particular drugs.
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
› Verified 8 days ago
Russell E Dodds, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 404 E Calhoun St, Anderson, SC 29621 Phone: 800-779-4858 Fax: 864-231-6448 | |
Dr. Susan Thrasher Martin, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 102 Buford Ave, Suite A, Anderson, SC 29621 Phone: 864-261-9506 Fax: 864-226-4201 | |
Dr. Benjamin Francis Emanuel, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 404 E Calhoun St, Anderson, SC 29621 Phone: 800-779-4858 Fax: 864-231-6448 | |
Leila Kutob, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1000 | |
Catherine Smith Jeffords, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 404 E Calhoun St, Anderson, SC 29621 Phone: 864-226-1558 | |
Dr. Earle Eugene Baillie, M.D, Pathology Medicare: Not Enrolled in Medicare Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 800-779-4858 Fax: 864-231-6448 |